Skip to main content
Fig. 2 | BMC Obesity

Fig. 2

From: Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery

Fig. 2

Receiver operating characteristic curves with area under the curve and standard error n parentheses for a multivariable model using all the preoperative liver function tests (except PTT due to a large proportion of missing values) and the ICG k value at pre-RYGB to predict significant fatty liver disease. Significant fatty liver, including nonalcoholic steatohepatitis (NASH) and NASH plus fibrosis, is defined as steatosis >5% with at least a few balloon cells and lobular inflammation >2 foci/200×. ICG = indocyanine green, PTT = Partial Thromboplastin Time, RYGB = Roux-en-Y gastric bypass

Back to article page